BALCHEM CORP
10QSB/A, 1995-08-14
CHEMICALS & ALLIED PRODUCTS
Previous: BADGER PAPER MILLS INC, 10-Q, 1995-08-14
Next: BALDOR ELECTRIC CO, 10-Q, 1995-08-14



                                 FORM 10-Q SB/A

                       SECURITIES AND EXCHANGE COMMISSION

                              Washington, DC 20549

                  Quarterly Report Under Section 13 or 15 (d)

                     of the Securities Exchange Act of 1934

        For Quarter Ended June 30, 1995      Commission File No. 1-13648



                              BALCHEM CORPORATION
             ------------------------------------------------------
             (Exact Name of Registrant as Specified in its Charter)


           Maryland                                          13-2578432
-------------------------------                  -------------------------------
(State of Other Jurisdiction of                  (I.R.S. Employer Identification
Incorporation or Organization)                                  Number)


    P.O. Box 175, Slate Hill, NY                              10973
----------------------------------------                    ----------
(Address of Principal Executive Offices)                    (Zip Code)


Registrant's Telephone Number, including area code:         (914)  355-2861
                                                            ---------------

   Indicate  by check mark  whether  the  registrant  (1) has filed all  reports
required to be filed by Section 13 or 15 (d) of the  Securities  Exchange Act of
1934  during  the  preceding  12 months  (or for such  shorter  period  that the
registrant was required to file such reports),  and (2) has been subject to such
filing requirements for the past 90 days.

                   Yes [ X ]         No  [    ]

   Indicate the number of shares  outstanding of each of the issuer's classes of
common stock, as of the close of the period covered by this report.

                         3,121,155 Shares Common Stock
<PAGE>
                              BALCHEM CORPORATION
                                 BALANCE SHEET
                                     ASSETS
<TABLE>
<CAPTION>
                                                      6/30/95         6/30/94
                                                   ------------    ------------
<S>                                                <C>             <C>         
CURRENT ASSETS
     Cash & Investments .......................    $     45,063    $     42,096
     Accounts Receivable ......................       2,527,928       1,850,404
     Inventories ..............................       1,527,808       1,152,589
     Pre-Paid Expenses ........................         299,670         359,299
     Deferred Income Taxes ....................          92,784          56,140
     Total Current Assets .....................       4,493,253       3,460,528
                                                   ------------    ------------

PROPERTY, PLANT, AND EQUIPMENT
     Land ...............................                53,648          53,648
     Building .................................       3,806,537       2,869,390
     Equipment ................................       9,506,093       9,078,783
         Total ................................      13,366,278      12,001,821
Less:  Accumulated Depreciation ...............       5,787,020       5,063,264
     Net:  Property, Plant, Equipment .........       7,579,258       6,938,557
                                                   ------------    ------------

OTHER ASSETS
     License Fees .............................          13,125          15,000
     Financing Costs ..........................          19,107          11,800
     Goodwill .................................           7,633           7,933
     Customer Lists ...........................         251,652            --
     Patents & Trademarks & Registrations .....         195,499         228,555
     Other ....................................          44,569          32,748
         Total Other Assets ...................         531,585         296,036
                                                   ------------    ------------

TOTAL ASSETS ..................................    $ 12,604,096    $ 10,695,121
                                                   ============    ============
</TABLE>
<PAGE>
                              BALCHEM CORPORATION
                           BALANCE SHEET (Continued)
                                    
<TABLE>
<CAPTION>
                                                      6/30/95         6/30/94
                                                   ------------    ------------
<S>                                                <C>             <C>         

                        LIABILITIES & STOCKHOLDER EQUITY
CURRENT LIABILITIES
     Payables (Trade & Accruals) ..............       1,799,159       1,145,672
     Notes Payable ............................          66,389         138,023
     Dividend payable .........................            --              --
     Line of Credit ...........................          45,000         800,000
     Bridge Loan ..............................            --           214,000
     Current Debt .............................         510,336         428,750
     Current Income Taxes .....................          22,120         (50,683)
         Total Current Liabilities ............       2,443,004       2,675,762
                                                   ------------    ------------

     Notes Payable Long Term ..................          40,960            --
     Bridge Loan ..............................            --         1,286,000
     Long Term Debt ...........................       2,760,000         841,667
     Deferred Income Tax ......................         617,316         508,544
     Deferred Compensation ....................          87,822          80,192

TOTAL LIABILITIES .............................       5,949,102       5,392,165
                                                   ------------    ------------

STOCKHOLDERS' EQUITY
     Common Stock .............................         208,069         138,168
     Paid-In-Capital ..........................       1,715,286       1,734,584
     Retained Earnings ........................       4,731,639       3,430,204
         Total Stockholders' Equity ...........       6,654,994       5,302,956
                                                   ------------    ------------

TOTAL LIABILITIES &
     STOCKHOLDERS' EQUITY .....................      12,604,096      10,695,121
                                                   ============    ============
</TABLE>
<PAGE>
                              BALCHEM CORPORATION
                            STATEMENT OF CASH FLOWS
               FOR PERIOD ENDING JUNE 30, 1995 and JUNE 30, 1994
<TABLE>
<CAPTION>
                                                          1995          1994
                                                          ----          ----
<S>                                                  <C>            <C>        
CASH FLOWS FROM OPERATING ACTIVITIES
    Net Earnings .................................   $   730,848    $   189,113

ADJUSTMENTS TO RECONCILE NET INCOME TO
NET CASH PROVIDED BY OPERATING ACTIVITIES
    Deferred Taxes ...............................        24,817         47,643
    Depreciation & Amortization ..................       398,044        300,224

CHANGES IN ASSETS & LIABILITIES
    Accounts Receivable ..........................        60,349        302,423
    Inventories ..................................      (225,934)      (152,382)
    Prepaid Expenses .............................       140,256        (82,879)
    Accounts Payable .............................      (274,069)       145,164
    Income Taxes Payable .........................       (68,100)      (149,820)
    Deferred Compensation Payable ................         4,018          3,405
    Total Adjustments ............................        59,381       413,778

NET CASH PROVIDED BY (USED IN)
OPERATING ACTIVITIES .............................       790,229        602,891

CASH FLOWS FROM INVESTING ACTIVITIES
    Capital Expenditures .........................      (488,913)    (1,908,585)
    Investments in Other Assets ..................      (123,429)        (9,718)
    Net Cash Used in Investing Activities ........      (612,342)    (1,918,303)

CASH FLOWS FROM FINANCING ACTIVITIES
    Net Borrowings Under Line of Credit ..........      (470,000)       (60,000)
    Notes Payable ................................      (160,266)       138,023 
    Bridge Loan ..................................                    1,500,000
    Note Payable Long Term .......................        (5,033)
    Proceeds from Long-Term Borrowings ...........     3,500,000           --
    Principal Payment on Short-Term Borrowings ...      (447,167)       (96,250)
    Principal Payments on Long-Term Debt .........    (2,509,500)      (181,250)
    Stock Options ................................         4,499          5,145
    Dividends Payable ............................       (85,802)       (68,929)

NET CASH PROVIDED BY (USED IN)
    FINANCING ACTIVITIES .........................      (173,269)     1,236,739

INCREASE (DECREASE) IN CASH ......................         4,618        (78,673)

CASH - BEGINNING .................................        40,445        120,769
CASH - ENDING ....................................   $    45,063    $    42,096
                                                     ===========    ===========
</TABLE>
<PAGE>
                              BALCHEM CORPORATION
                  SUMMARIZED FINANCIAL INFORMATION (UNAUDITED)
                                INCOME STATEMENT

<TABLE>
<CAPTION>
                                        For the                           For the                           For the
                                   Three Months Ended      %          Six Months Ended       %        Three Months Ended       %
                                 ----------------------   ----    -----------------------   ----     ---------------------    ----
                                  6/30/95      6/30/94             6/30/95       6/30/94              6/30/95      3/31/95
                                 ---------    ---------           ----------    ---------            ---------    ---------  
<S>                              <C>          <C>         <C>     <C>           <C>         <C>      <C>          <C>         <C>  
Sales & Other Revenues ......    5,826,793    3,884,287   50.0    11,763,816    7,630,642   54.2     5,826,793    5,937,023   (1.9)
                                 ---------    ---------           ----------    ---------            ---------    ---------        

Cost of Sales ...............    3,073,256    2,266,551   35.6     6,321,175    4,410,144   43.3     3,073,256    3,247,920   (5.3)

Interest Expense ............       90,517       53,080   70.5       177,991       96,623   84.2        90,517       87,474    3.5

Other Expenses ..............    2,086,673    1,416,613   47.3     4,148,775    2,813,371   47.5     2,086,673    2,062,101    1.2
                                 ---------    ---------           ----------    ---------            ---------    ---------        

Operating Costs and
     Expenses ...............    5,250,446    3,736,244   40.5    10,647,941    7,320,138   45.5     5,250,446    5,397,495   (2.7)

Pre-Tax Operating
     Earnings ...............      576,347      148,043   >100     1,115,875      310,504   >100       576,347    539,528    6.8

Income Taxes ................      197,532       25,833              385,027      121,421              197,532      187,495

Net Income ..................      378,815      122,210   >100       730,848      189,083   >100       378,815      352,033    7.6

Number of
     Outstanding Shares(*) ..    3,121,155    3,090,395            3,121,155    3,090,395            3,121,155    3,120,059

Earnings Per Share
     Before Taxes ...........        0.185        0.048                0.358        0.100                0.185        0.173
     After Taxes ............        0.121        0.040                0.234        0.061                0.121        0.113
</TABLE>

--------------------------------------
(*)1994 shares adjusted for 3 for 2 stock split in October 1994.
<PAGE>
                       MANAGEMENT DISCUSSION AND ANALYSIS


REVENUES

Revenues  increased 50% for the quarter  ending  6/30/95 vs. the quarter  ending
6/30/94,and  54.2%  comparing  the six  months  ended  6/30/95  and  6/30/94,  a
percentage  of which is  attributed to increased  revenues  generated  from core
business and commercialization of prospects.  The remainder of increased revenue
results  from a full year of  absorption  of former  AlliedSignal  accounts of a
drummed specialty chemical, whose customer list was purchased by Registrant July
1, 1994.

Revenues  decreased  1.9%  comparing the quarter  ended 6/30/95 to 3/31/95;  the
decline is too small to be attributed any significance.


OPERATIONAL COSTS AND EXPENSES

Cost of sales  increased 35.6% for the quarter ended 6/30/95  comparing  6/30/94
and 43.3% for the six months ended  6/30/95 and 6/30/94 as a result of increased
pricing on raw material purchases, addition of plant personnel in correlation to
revenue  increases,  depreciation of assets in relation to new drumming  station
and equipment at the Green Pond, South Carolina  facility and overall  increased
expenses to support business conditions as so described above.

Cost of sales  decreased 5.3% from the 1Q '95 to 2Q '95 due to  resignations  of
personnel at the plant level, positions which were not immediately replaced.

Interest  expense  increased  70.5% for the quarter ending 6/30/95 vs.  6/30/94,
84.2%  comparing  the six months ended 6/30/95 and 6/30/94 and by only 3.5% from
the 1Q '95 to the 2Q '95  which  are  attributed  to the  financing  of  certain
AlliedSignal  assets,  the drumming  station at the Green Pond,  South  Carolina
facility and higher credit line balances during the second half of 1994.

Other expenses increased 47.3% for the quarter ended 6/30 95 vs. 6/30/94,  47.5%
comparing  the six months  ended  6/30/95 and 6/30/94 and 1.2% from 1Q '95 to 2Q
'95. The increases are attributed to increased business as described from 2Q '94
to 2Q '95 such as expansion of corporate truck fleet with corresponding  expense
in personnel and operations,  recruiting of professional with related recruiting
and  benefit  expense  and  increased  moving  expense  for  the  relocation  of
professionals  hired in 4Q '94  through  2Q '95.  Other  increased  expense  was
associated with increased travel into international  markets in Europe and South
East Asia.


PRE-TAX EARNINGS

Pre-tax earnings  increased  $428,043 or >100% for the quarter ended 6/30/95 vs.
6/30/94, $805,371 or >100% for the six months ended 6/30/95 and 6/30/94 and 6.8%
from the 1Q '95 to the 2Q '95 in direct  correlation  to business  conditions as
described during this time frame.


OTHER

INVENTORIES

Inventories as stated for periods ended 6/30/95 and 6/30/94 were  $1,527,808 and
1,129,374 inclusive of the following breakdown:

<TABLE>
<CAPTION>
                                                     1995                 1994
                                                     ----                 ----
<S>                                              <C>                  <C>       
Raw Materials ........................           $  705,205           $  540,532

Finished Product .....................              822,603              588,842

Work in Process ......................                 --                   --


Total Inventory ......................           $1,527,808           $1,129,374
</TABLE>


ADJUSTMENTS

In  the  opinion  of   Management,   accompanying   financial   statements   are
representative  of all adjustments  necessary to fairly present the consolidated
financial position as of June 30, 1995 and 1994.
<PAGE>
                                   SIGNATURE



         Pursuant to the requirement of the Securities  Exchange Act of 1934 the
Registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned therewith duly authorized.



                              BALCHEM CORPORATION
                                  (Registrant)



                       BY  /s/ Herb Weiss
                          ------------------------------
                                   Herb Weiss
                            President, Treasurer and
                            Chief Financial Officer





Dated:  August 2, 1995

<TABLE> <S> <C>

<ARTICLE> 5
       
<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          JAN-31-1995
<PERIOD-END>                               JUN-30-1995
<CASH>                                          45,063
<SECURITIES>                                         0
<RECEIVABLES>                                2,527,928
<ALLOWANCES>                                         0
<INVENTORY>                                  1,527,808
<CURRENT-ASSETS>                             4,493,253
<PP&E>                                      13,366,278
<DEPRECIATION>                               5,787,020
<TOTAL-ASSETS>                              12,604,096
<CURRENT-LIABILITIES>                        2,443,004
<BONDS>                                              0
<COMMON>                                       208,069
                                0
                                          0
<OTHER-SE>                                   6,446,925
<TOTAL-LIABILITY-AND-EQUITY>                 6,654,994
<SALES>                                      5,826,793
<TOTAL-REVENUES>                             5,826,793
<CGS>                                        3,073,256
<TOTAL-COSTS>                                5,250,446
<OTHER-EXPENSES>                             2,086,673
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                              90,517
<INCOME-PRETAX>                                576,347
<INCOME-TAX>                                   197,532
<INCOME-CONTINUING>                            378,815
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   378,815
<EPS-PRIMARY>                                     .125
<EPS-DILUTED>                                        0
        


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission